China Money Network
Login
Join

China’s Biopharma Firm Gan & Lee Teams Up With Novartis In Global Insulin Push

  • December 20, 2018 — 10:32 CST

This Data Is Locked!

This area is available only to Subscribers.

Gan & Lee Pharmaceuticals, a biopharmaceutical company specializing in insulin and insulin analogues in China, announced that it has entered into an agreement to commercialize... [DATA LOCKED]

UNLOCK DATA

Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals

Join

Access Thousands of Data Points to Monitor Chinese Private Equity Deal Movement and Relationships

Already Have an Account?

Login
Related Topics:

Related Data: